Early detection of infectiousness is key to stopping the spread of COVID-19 and reopening the economy.
Screening Site Set-Up
Project Kickoff, Resource Requirements, Signing Up Your Workforce, Ordering and Managing Screens & Supplies
Screening Site Operations
Administering Screens, Waste Management, Results Communication and Management, Data Management and Reporting, Central Data Infrastructure
Key explainer articles, scientific studies, and additional resources for implementing a workplace rapid screening program.
Popular ArticlesAssembling a Site Implementation Team Project Kickoff Screening Station Layout and Setup Signing Up Your Workforce Design Basis and Bill of Materials Sample Collection, Processing, and Analysis Rapid Antigen Screening Ordering and Managing Screens Preparation to Administer Screens Frequently Asked Questions
This Playbook is intended for organizations conducting rapid antigen, point-of-care screening (herein referred to as rapid antigen screening) in Canada. This guidance provides basic information only. It does not take the place of medical advice, diagnosis, treatment, or legal advice.
Rapid antigen testing is used for screening purposes only and should NOT be used for diagnosis of COVID-19 infection or any other illness. Rapid antigen testing or screening does not prevent someone from getting COVID-19.
Rapid antigen screening can be thought of as a screening tool and does not replace public health measures such as symptom screening, physical distancing, masking, hand hygiene and respiratory etiquette. It also does not replace requirements to protect the health and safety of workers.
Any positive results from rapid antigen screening must be confirmed with laboratory-based testing.
Anyone who falls within the current Provincial testing guidance should continue to seek testing at available participating pharmacies, participating licensed community labs, and assessment centres.
In the event of any conflict between this guidance Playbook and any applicable legislation or orders or directives issued by Federal or Provincial health authorities, the legislation, order or directive prevails.
The material in this Playbook is provided on an ‘as is’ and “as available” basis, without any conditions, warranties or guarantees of any kind, whether express, implied, statutory or otherwise. CDL Rapid Screening Consortium (CDL RSC) does not give any condition, warranty or guarantee as to the accuracy, reliability or completeness of information which is contained in this Playbook and excludes all representations, warranties, conditions and other terms (including, without limitation, to the extent permitted by law, any conditions of non-infringement, satisfactory quality, fitness for a specific or general purpose and the use of reasonable care and skill). CDL RSC does not accept any liability for any error or omission in this Playbook or for any resulting loss or damage suffered by the recipient or any other person. Reliance on any information contained in this Playbook or provided by CDL RSC, its members and their respective employees is solely at your own risk.
This Playbook may contain information brought to you by third parties or through links to other Internet websites. Notice of information or links of this kind is provided throughout the Playbook. CDL RSC does not control nor assume any responsibility for the information provided by third parties or the content of other Internet websites to which links are provided. CDL RSC does not guarantee the accuracy of information in the Playbook, including information provided by third parties, at any particular time.
Unless otherwise specified, copyright of information provided in the Playbook is owned by CDL RSC. You may not re-publish, broadcast, copy, transmit, alter or modify this information in any way, including the removal of this copyright notice.